Luca Testa

Luca Testa

Interventional cardiologist / Cardiologist
IRCCS Policlinico San Donato - San Donato Milanese, Italy

Latest contributions

When high calcium burden meets a 75 year-old patient with previous CABG + SAVR + MVr

02 Jul 2025

This case illustrates how a fragile patient with severe three-vessel disease involving LM/LAD was treated. Watch now to find out more, and share your thoughts!

Filippo Pensotti

Author

Filippo Pensotti
Luca Testa

Author

Luca Testa

Acute complications during distal left main PCI - Part 3

22 May 2025 – From EuroPCR 2025

This session highlights acute complications during distal left main PCI. It presents cautionary cases of incorrect left main stenting, catastrophic left main V stenting outcomes, unprotected left main thrombosis, and survival strategies when new technologies fail unexpectedly.

Acute complications during distal left main PCI - Part 3

Which valve is best for my patient?

21 May 2025 – From EuroPCR 2025

This session guides clinicians in selecting the most appropriate transcatheter aortic valve tailored to individual patient characteristics. Through diverse case discussions, including patients with coronary artery disease, small anatomies, bicuspid valves, and surgical bioprostheses, it elucidates decision-making processes and planning for complex TAVI anatomies.

Which valve is best for my patient?

Hotline TAVI 2: outcomes with new and established devices

21 May 2025 – From EuroPCR 2025

Review outcomes of new and established TAVI devices through pooled analyses and multicenter studies. Topics include comparisons of balloon-expandable valves, intra- versus supra-annular self-expanding valves, and insights from the ACURATE IDE and ACURATE prime studies.

Hotline TAVI 2: outcomes with new and established devices

Align for the future with the Myval Octapro transcatheter heart valve series

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.

Clinical insights are backed by key data...

Align for the future with the Myval Octapro transcatheter heart valve series

Pushing the boundaries to optimise patient outcomes: from planning to success

26 Nov 2024 – From PCR London Valves 2024

Learn from experts about achieving optimal TAVI outcomes, tailoring approaches for lifetime management, and mastering tips for diverse anatomical challenges.

Pushing the boundaries to optimise patient outcomes: from planning to success

Featured cases - Challenging TAVI scenarios

26 Nov 2024 – From PCR London Valves 2024

Explore this curated collection of challenging TAVI cases from PCR London Valves 2024. Discover innovative techniques and strategies employed to navigate complex anatomies, including TAVR with coronary protection, 3D ICE-guided antegrade TAVR, no-contrast TAVI in end-stage renal disease, and snare-assisted TAVI for precision. Gain insights into...

Featured cases - Challenging TAVI scenarios

Non-transfemoral TAVI - The toolkit

25 Nov 2024 – From PCR London Valves 2024

When should you consider alternative access for TAVI instead of the transfemoral route? This video dives right into the different non-transfemoral approaches, from transsubclavian to transcaval, and explains when each technique is most appropriate.

Learn how vascular modification can expand access options for more patients and discover...

Non-transfemoral TAVI - The toolkit

TAVI for aortic regurgitation

25 Nov 2024 – From PCR London Valves 2024

Curious about advancing your knowledge in TAVI for aortic regurgitation? Don’t miss this video!

You'll dive into the diagnostic and treatment strategies to optimize outcomes in patients with aortic regurgitation, explore groundbreaking technologies like the Jenavalve Trilogy THV system and gain insights from the latest clinical evidence and...

TAVI for aortic regurgitation

DCB digital crosstalk: practice patterns for patients with diabetes and diffuse disease in Europe

07 Oct 2024

Watch the replay of this webinar on the concept of DCB in native vessel disease and so much more!

TAVI hotline: long-term registry data

15 May 2024 – From EuroPCR 2024

This session presents and discusses long-term registry data on various aspects of transcatheter aortic valve implantation (TAVI). It covers topics such as the surgical versus transcatheter approach in combined coronary and aortic valve disease, long-term outcomes of TAVI versus surgical aortic valve replacement, and registry data...

TAVI hotline: long-term registry data

Align for the future with next-generation balloon expandable THV technology

15 May 2024 – From EuroPCR 2024

In this session, explore the next-generation balloon-expandable Myval Octacor THV, focusing on its key features, procedural impact, and potential clinical benefits. Understand the procedural steps for planning and implanting it, especially for intermediate and extra-large sizes, using the Octalign technique. Learn about the unmet clinical need...

Align for the future with next-generation balloon expandable transcatheter heart valve technology

PCI in patients with diabetes: next generation DES + DCB stent platform in action

14 May 2024 – From EuroPCR 2024

Watch this session on PCI in diabetic patients to learn about a groundbreaking technology addressing the complexities of this critical subgroup. Discover the next-generation DES and DCB stent platform and the innovative Envisolution technology behind it. Understand how it works, its advantages in managing complex cases,...

PCI in patients with diabetes: next generation DES + DCB stent platform in action

The next generation DES technology: innovative DES+DCB stent platform

Next generation of DES technology, what it's all about? Find out in this session where experts will present complex cases from around the world and discuss the new indications for which they can be used.

The next generation DES technology: innovative DES+DCB stent platform

Next generation balloon expandable TAVR and thin strut BRS - Science and clinical update

17 May 2023 – From EuroPCR 2023

Join this session for an update on the science and clinical advancements in next-generation balloon-expandable transcatheter aortic valve replacement (TAVR) and thin strut bioresorbable scaffolds (BRS). Discover how these innovative technologies can improve clinical outcomes by exploring case-based challenging scenarios and learn effective strategies for tackling...

Going down the road of coronary artery disease treatment: sirolimus-coated balloon and DES + DCB stent platform

16 May 2023 – From EuroPCR 2023

What better way to talk about sirolimus-coated balloons than with real-life clinical cases? In this session, study the case of a 78-year-old man with crescendo angina and inferior wall ischaemia, or a 48-year-old woman with crescendo angina, type 2 DM and anterior wall hypokinesia with mild...

Haemodynamic performance of transcatheter aortic valves: practical considerations for lifetime management

28 Nov 2022 – From PCR London Valves 2022

Watch this highly interactive session which focuses on the impact of haemodynamic performance on valve durability and patient survival, and how the design of bioprosthetic aortic valves influences clinical outcomes.

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!

19 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!

The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms

18 May 2022 – From EuroPCR 2022

Alexandre Abizaid, Marco Valgimigli, Fazila Malik, Luca Testa, Patrick W. Serruys, Damiano Regazzoli, Kumar Prathap, and Sandeep Basavarajaiah take turns in this session to discuss two innovative technologies: a stent platform with nanotechnology and a novel drug-coated balloon (DCB). These novel technologies both have unique features...

The ability to transform coronary artery disease treatment: innovative nanotechnology-based sirolimus DES and DCB platforms

EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: TRANSIT-PPM, LYTEN, SCOPE 2, and more!

18 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in TAVI! Balloon vs. self-expanding valves in valve-in-valve TAVI, trilogy for treatment of aortic regurgitation, management of Myocardial Revascularization in Patients with Stable Coronary Artery Disease Undergoing TAVI, SCOPE 2 subanalysis, prosthesis-patient mismatch following TAVR, and stroke complicating...

EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: TRANSIT-PPM, LYTEN, SCOPE 2, and more!

Abluminus DES+: an innovative solution going global to beat diabetes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roxana Mehran, Luca Testa, Alexandre Abizaid and Marie-Claude Morice in order to know more about the need of a dedicated DES+ for diabetic patients and the technology behind it and the updates on ongoing and upcoming studies and trials, as well...

Abluminus DES+: an innovative solution going global to beat diabetes

Addressing diabetes globally with an innovative solution

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roxana Mehran, Luca Testa and Alexandre Abizaid in order to understand the need to address diabetes with a dedicated solution, to learn how the DES+DCB platform can help counter DM in PCI, and to get insights into the ongoing and upcoming clinical programs.

View...

Addressing diabetes globally with an innovative solution

XLIMIT - Randomised controlled trial to assess endothelisation of Xlimus DES

18 May 2021 – From EuroPCR 2021

Watch this session presented by Luca Testa in order to know about XLIMIT randomised clinical trial, and to learn about Xlimus DES stent with Sirolimus and bioabsorbable polymer coating.

XLIMIT - Randomised controlled trial to assess endothelisation of Xlimus DES

Innovative solutions to treat diabetic patients

Watch this video if you want to understand the need of dedicated DES for Diabetes Mellitus (DM) patients, to understand and learn the differences of CAD for diabetic compared to non-diabetic patients, to see clinical evidences and results for the treatment of Diabetic patients with DES+...

Innovative solutions to treat diabetic patients

Abstracts on stent & scaffolds - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of abstracts from PCR e-Course 2020 on the topic of Stents & scaffolds:

  • 12-month follow-up results of the first cohort of the BIOSOLVE-IV registry
  • The effects of shockwave lithotripsy on DES
  • 5-year data of the drug-eluting absorbable metal scaffold in BIOSOLVE-II
  • Bailout stenting post drug coated balloons;...
Abstracts on Stent & scaffolds - PCR e-Course 2020

Hope for improved PCI outcomes in diabetic patients with the Abluminus stent

Although huge progress has been made over the last four decades in percutaneous coronary intervention, the results in diabetic patients are still suboptimal, with higher rates of restenosis, target lesion revascularisation, vessel failures and mortality. Luca Testa, Roxana Mehran and Ashok Seth discuss the problems that...

Hope for improved PCI outcomes in diabetic patients with the Abluminus stent

Ability to treat diabetic patients: DES + DCB strategy

23 May 2019 – From EuroPCR 2019

Consult this session to get insights about the need for a dedicated drug eluting stent (DES), as well as the benefits of a DES+DCB strategy, for diabetes mellitus (DM) and acute MI (AMI) patients.

Ability to treat diabetic patients: DES + DCB strategy

Trials and registries - Long term clinical outcomes after TAVI

21 May 2019 – From EuroPCR 2019

Consult this session to learn about the latest trials and registries regarding the long term clinical outcomes after TAVI, such as CHOICE, INTeNSE, RASTAVI, and more!